|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Boston Biomedical Research Institute, 64 Grove Street, Watertown, MA 02472, USA2 Center for Cell Signalling, University of Virginia, 1400 Jefferson Park Avenue, Charlottesville, VA 22908, USA
Ca2+ sensitivity of arterial contractility is governed by regulating myosin phosphatase activity in response to agonist stimuli. CPI-17, a myosin phosphatase inhibitor phosphoprotein, is phosphorylated concomitantly with agonist-induced contractile Ca2+ sensitization in mammalian artery. CPI-17 has not been detected in chicken artery, but is readily detectable in pigeon artery. To evaluate a role of CPI-17, we compared contractility of the arteries of CPI-17-deficient chicken with those of CPI-17-rich rabbit and pigeon, and studied the effect of CPI-17-reconstitution in chicken artery. Other major regulatory/contractile proteins for Ca2+ sensitization are expressed in both chicken and rabbit arteries. Agonists, such as an
1-agonist and endothelin-1, produced significant contraction in arteries of all species under physiological Ca2+-containing conditions. Depletion of Ca2+ abolished these contractions in chicken but partially inhibited them in rabbit and pigeon arteries. Unlike CPI-17-rich tissues, chicken arteries exerted little Ca2+ sensitization in response to
1-agonist or endothelin-1. GTP
S produced a slight Ca2+ sensitizing effect in chicken artery, but this was significantly smaller compared with CPI-17-rich tissues. A PKC activator (PDBu) did not generate but rather reduced a contraction in both intact and
-toxin-permeabilized chicken artery in contrast to a large contraction in CPI-17-rich arteries. Myosin light chain phosphorylation was reduced by PDBu in chicken but elevated in rabbit artery. Addition of recombinant CPI-17 into ß-escin-permeabilized chicken artery restored PDBu-induced and enhanced GTP
S-induced Ca2+ sensitization. Thus, CPI-17 is essential for G protein/PKC-mediated Ca2+ sensitization in smooth muscle.
(Received 15 March 2004;
accepted after revision 16 April 2004;
first published online 16 April 2004)
Corresponding author T. Kitazawa: Boston Biomedical Research Institute, 64 Grove Street, Watertown, MA 02472, USA. Email: kitazawa{at}bbri.org
This article has been cited by other articles:
![]() |
G. J. Dimopoulos, S. Semba, K. Kitazawa, M. Eto, and T. Kitazawa Ca2+-Dependent Rapid Ca2+ Sensitization of Contraction in Arterial Smooth Muscle Circ. Res., January 5, 2007; 100(1): 121 - 129. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. P. Woodsome, A. Polzin, K. Kitazawa, M. Eto, and T. Kitazawa Agonist- and depolarization-induced signals for myosin light chain phosphorylation and force generation of cultured vascular smooth muscle cells J. Cell Sci., May 1, 2006; 119(9): 1769 - 1780. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Pang, Z. Guo, Z. Xie, W. Su, and M. C. Gong Divergent kinase signaling mediates agonist-induced phosphorylation of phosphatase inhibitory proteins PHI-1 and CPI-17 in vascular smooth muscle cells Am J Physiol Cell Physiol, March 1, 2006; 290(3): C892 - C899. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Pang, Z. Guo, W. Su, Z. Xie, M. Eto, and M. C. Gong RhoA-Rho kinase pathway mediates thrombin- and U-46619-induced phosphorylation of a myosin phosphatase inhibitor, CPI-17, in vascular smooth muscle cells Am J Physiol Cell Physiol, August 1, 2005; 289(2): C352 - C360. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Matsuzawa, S.-i. Aikawa, S.-y. Ohki, and M. Eto Phospho-Pivot Modeling Predicts Specific Interactions of Protein Phosphatase-1 with a Phospho-Inhibitor Protein CPI-17 J. Biochem., May 1, 2005; 137(5): 633 - 641. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-M. Hai and H. R. Kim An expanded latch-bridge model of protein kinase C-mediated smooth muscle contraction J Appl Physiol, April 1, 2005; 98(4): 1356 - 1365. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |